title: Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation.
authors.affiliation: Department of Nephrology, Charité, Campus Virchow-Klinikum, Berlin, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Kahl
authors.forename: M
authors.initials: M
authors.lastname: Oppert
authors.forename: A
authors.initials: A
authors.lastname: Müller
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
authors.forename: J
authors.initials: J
authors.lastname: Lepenies
authors.forename: J
authors.initials: J
authors.lastname: Klupp
authors.forename: D
authors.initials: D
authors.lastname: Kampf
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
authors.forename: U
authors.initials: U
authors.lastname: Frei
mesh_terms: D000328:Adult; D017668:Age of Onset; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000276:immunology*; D006435:Renal Dialysis; D012189:Retrospective Studies; D020123:Sirolimus / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D020123:Sirolimus